News
10-31-2022, 08:37 PM
The Breast Cancer Research Foundation (BCRF) has renewed its funding to Elisa Port, MD, and Hanna Irie, MD, PhD, to study new therapeutic approaches that target aggressive triple-negative breast cancer.
More... (https://www.news-medical.net/news/20221031/BCRF-renews-funding-to-support-the-development-of-novel-therapeutics-for-triple-negative-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20221031/BCRF-renews-funding-to-support-the-development-of-novel-therapeutics-for-triple-negative-breast-cancer.aspx)